SCHEMBL9210381

SCHEMBL9210381

CCCCc1cn(C2C(C)CCCCCC2C(=O)O)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)nc1

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 16/20 0.64
AGTR2 P50052 14/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9274002 0.99 AGTR1 (0.64) AGTR1AGTR2
SCHEMBL9201600 0.98 AGTR1 (0.66) AGTR1AGTR2
SCHEMBL9208108 0.95 AGTR1 (0.62) AGTR1AGTR2
SCHEMBL9207557 0.94 AGTR1 (0.64) AGTR1AGTR2
SCHEMBL9202162 0.93 AGTR1 (0.72) AGTR1AGTR2
SCHEMBL9205090 0.93 AGTR1 (0.66) AGTR1AGTR2
SCHEMBL9202031 0.93 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL9289611 0.92 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9276736 0.92 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9276419 0.92 AGTR1 (0.57) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0664803-A1 N-ARYLHETEROARYLALKYL 1-CYCLOALKYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1995-08-02 EP disclosed
WO-1994008989-A1 N-ARYLHETEROARYLALKYL 1-CYCLOALKYL-IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1994-04-28 WO disclosed